Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 is enclosed.

£ ACUTAAS CHEMICALS LIMITED A (Formerly known as Ami Organics Limited) CIN No. : L24100GJ2007PLC051093 You and us: chemistry’s apex October 27, 2026 To, To, The Listing Department, The Listing Department BSE LIMITED, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, 5" Floor, Plot no. C-1, Dalal Street, Fort G-Block, Bandra Kurla Complex, Mumbai- 400 001 Mumbai -400051 Scrip Code: 543349 NSE Symbol: ACUTAAS Subject: Unaudited Standalone & Consolidated Financial Results for the second quarter & half year ended September 30, 2026 We would like to inform that the Board of Directors at its meeting held on October 27, 2026 inter alia, considered and approved the Unaudited Standalone and consolidated Financial Results for the second quarter & half year ended September 30, 2026 as recommended by the Audit Committee. The Board also took note of the 'Limited Review Report' issued by the Company’s Statutory Auditors, M/s. Maheshwari & Co. Chartered Accountants. We enclose herewith the following: 1. Statement showing the Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended September 30, 2026. . Standalone & Consolidated Balance Sheet as on 30" September, 2026. 3. Standalone and Consolidated Cash Flow Statement for the half year ended 30" September, 2026. Limited Review Report on standalone and consolidated financial statements issued by the Statutory Auditors of the Company. As required under Regulation 47 (1) (b) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the extract of the Financial Results will be published in the newspapers in the format prescribed by SEBI. The Financial Results will also be available on the Company's website at www.acutaas.com. Kindly take above as compliance of Regulation 33 and 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board Meeting commenced at 11.30 A.M. and concluded at [2-35 P. M Thanking you, For, ACUTAAS CHEMICALS LIMITED Ewr,wmz\i Ekta Kumari Srivastava Company Secretary & Compliance Officer Encl: As above L +9175730 15366, +91 72279 77744 Q Registered Office: Plot No. 440/4, 5 & 6, 7% info@acutaas.com Road No. 82/A, GIDC Sachin, www.acutaas.com Dist. Surat- 394230, Gujarat, India Maheshwari & Co. Chartered Accountants Independent Auditor’s Review Report on Review of Interim Standalone Financial Results To The Board of Directors, Acutaas Chemicals Limited (formerly known as Ami Organics Limited) 1. We have reviewed the accompanying Statement of Standalone Unaudited Financial Results of Acutaas Chemicals Limited (‘hereinafter referred to as “the Company™) for the quarter and six months ended September 30,2026 (“the Statement™), attached herewith, being submitted by the Company pursuant to the requirements of the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“the Listed Regulations™) 2. This Statement which is the responsibility of the Company's Management and approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 (‘the Act’) as amended, read with relevant rules issued thereunder (“Ind AS 34”) and other recognized accounting principles generally accepted in India and is in compliance with the regulations. Our responsibility is to issue a report on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India (ICAI). This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in aforesaid Indian Accounting Standard (“Ind AS 34”) and other recognized accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Regulation 33 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Maheshwari & Co. Chartered Accountants Firm’s Registration No.: 105834W Kriti Bansal Partner Place: Mumbai Membership No.: 459589 'UDIN: 26459589SZBZRV8396 Date: October 27, 2026 Office: 1302/1303, Solaris One, Vijay Nagar, Opp. Teli Gali, Andheri (East), 400069 Head office: 10-11, Third Floor, Esplanade Building, 3 A K Naik Marg (Bestian Road), Near New Empire Cinema, Fort, CST, Mumbai 400 001 Tel.: +91-22-22077472/22072620, E-mail: vkasawa@maheshwariandco.in, Website: www.maheshwariandco.in ACUTAAS CHEMICALS LIMITED (Formerly known as Ami Organics Limited) CIN: L241006J2007PLC051093 Registered office: 440/4 5 6, Road No 824, Sachin GIDC, Surat, Guj: t - 394 230, Indi Tel: +91 72279 77744; +91 75730 15366 Website: www.acutaas.com Email: cs@acutaas.com Unaudited Standalone Financial Results for the Quarter and Half Year Ended September 30, 2026 (Fintakhs, unless othanvise stted) Quarter Ended Walf Vear Ended Vear Ended partculars ‘September 30, 2026] _June 30, 2026 _| September 30, 2025 September 30, 2026| September 30,2025| _March 31, 2026 Una Unaudited Unaudited Unaudited Audited Income Revenue from operations 330085 32,2092 3051934 7550577 s111643 237822 Otner income 805 760 89595 125236 249896 458783 Total Income a,100.01 268852 3141629 7679793 5361539 136,967.05 Expenses Cost of materials consumed 1550840, 1639725 1300256 3190165 232027 59,2699 Changes ininventores of fnshed goods, stock-in rade and work-in-progress 7729 (2.3367) s13s1 (1,650.38) (140.72) (3,088.80) Employee beneits expense: 395119 374036 286388 789135 530413 11,1348, Finance costs 9938 11179 5720 a1y 1915 30772 Depraciation and amortization expense: 93130 20202 m 183332 151845 330322 Other expenses. 470077 3589.47 447876 83102 787326 1676262 (Tota! expenses 2600153 225702 2168815 a8,28835 37,99455 87.58956 Protivoss) betora exceptional tems and tax 18.108.08 1040150 97834 250958 1562088 527735 Exceptionatitems. B s - = 5 2 rfit(ioss) betore tax 1810808 1040150 572814 250958 1552088 927739 Taxexpense Current tax 3oms 255325 183520 647577 320802 1150905 Deferred tax 61150 25868 50378, 87058 55902 111088 Totaltax expense as3aa2 za1iss 243898 7,346.35 | 387.06 1255990 Profitftohre period Bs73es 758957 728916 2116323 1175378 3661745 Other comprehensive Income (och) Items that il not be reclassified to profit o loss. | Remeasuremento defined employee berefit pians (778 e (3997) (5743 w3s2) (850) Taximpact on ers thatwil ot be reclassfieod profitorloss 20 243 1008 1045 1098 a7 Total other comprehensive income (noef tatx) 13576) .22] [E) Tazs8) (5260) 12839) Total compreensive income for the period 1353790 758235 725935 213025 ErRRTy 3658856 Detailosf equity share capital 409356 409356, 409356 409355 409356 409355, Eauity shares of face value Rs. 5/~ eac [Showing first 8,000 characters — download PDF for full document]